These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 28851816)

  • 1. FOXD3 Regulates CSC Marker, DCLK1-S, and Invasive Potential: Prognostic Implications in Colon Cancer.
    Sarkar S; O'Connell MR; Okugawa Y; Lee BS; Toiyama Y; Kusunoki M; Daboval RD; Goel A; Singh P
    Mol Cancer Res; 2017 Dec; 15(12):1678-1691. PubMed ID: 28851816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic changes and alternate promoter usage by human colon cancers for expressing DCLK1-isoforms: Clinical Implications.
    O'Connell MR; Sarkar S; Luthra GK; Okugawa Y; Toiyama Y; Gajjar AH; Qiu S; Goel A; Singh P
    Sci Rep; 2015 Oct; 5():14983. PubMed ID: 26447334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel antibody against cancer stem cell biomarker, DCLK1-S, is potentially useful for assessing colon cancer risk after screening colonoscopy.
    Sarkar S; Popov VL; O'Connell MR; Stevenson HL; Lee BS; Obeid RA; Luthra GK; Singh P
    Lab Invest; 2017 Oct; 97(10):1245-1261. PubMed ID: 28414327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation of the DCLK1 promoter region in circulating free DNA and its prognostic value in lung cancer patients.
    Powrózek T; Krawczyk P; Nicoś M; Kuźnar-Kamińska B; Batura-Gabryel H; Milanowski J
    Clin Transl Oncol; 2016 Apr; 18(4):398-404. PubMed ID: 26311076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Histone Demethylase KDM3A, Increased in Human Pancreatic Tumors, Regulates Expression of DCLK1 and Promotes Tumorigenesis in Mice.
    Dandawate P; Ghosh C; Palaniyandi K; Paul S; Rawal S; Pradhan R; Sayed AAA; Choudhury S; Standing D; Subramaniam D; Padhye SB; Gunewardena S; Thomas SM; Neil MO; Tawfik O; Welch DR; Jensen RA; Maliski S; Weir S; Iwakuma T; Anant S; Dhar A
    Gastroenterology; 2019 Dec; 157(6):1646-1659.e11. PubMed ID: 31442435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-137 Regulates the Tumorigenicity of Colon Cancer Stem Cells through the Inhibition of DCLK1.
    Sakaguchi M; Hisamori S; Oshima N; Sato F; Shimono Y; Sakai Y
    Mol Cancer Res; 2016 Apr; 14(4):354-62. PubMed ID: 26747706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DCLK1 plays an important role in colorectal cancer tumorgenesis through the regulation of miR-200c.
    Mohammadi Y; Tavangar SM; Saidijam M; Amini R; Etemadi K; Karimi Dermani F; Najafi R
    Biomed Pharmacother; 2018 Jul; 103():301-307. PubMed ID: 29656186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DCLK1 integrates induction of TRIB3, EMT, drug resistance and poor prognosis in colorectal cancer.
    Makino S; Takahashi H; Okuzaki D; Miyoshi N; Haraguchi N; Hata T; Matsuda C; Yamamoto H; Mizushima T; Mori M; Doki Y
    Carcinogenesis; 2020 May; 41(3):303-312. PubMed ID: 31562741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic regulation of human
    Singh P; O'Connell M; Shubhashish S
    Stem Cell Investig; 2016; 3():51. PubMed ID: 27777940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doublecortin and CaM kinase-like-1 expression in pathological stage I non-small cell lung cancer.
    Tao H; Tanaka T; Okabe K
    J Cancer Res Clin Oncol; 2017 Aug; 143(8):1449-1459. PubMed ID: 28382517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dclk1, a tumor stem cell marker, regulates pro-survival signaling and self-renewal of intestinal tumor cells.
    Chandrakesan P; Yao J; Qu D; May R; Weygant N; Ge Y; Ali N; Sureban SM; Gude M; Vega K; Bannerman-Menson E; Xia L; Bronze M; An G; Houchen CW
    Mol Cancer; 2017 Feb; 16(1):30. PubMed ID: 28148261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DCLK1 is a broadly dysregulated target against epithelial-mesenchymal transition, focal adhesion, and stemness in clear cell renal carcinoma.
    Weygant N; Qu D; May R; Tierney RM; Berry WL; Zhao L; Agarwal S; Chandrakesan P; Chinthalapally HR; Murphy NT; Li JD; Sureban SM; Schlosser MJ; Tomasek JJ; Houchen CW
    Oncotarget; 2015 Feb; 6(4):2193-205. PubMed ID: 25605241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic Neuroendocrine Tumors and EMT Behavior Are Driven by the CSC Marker DCLK1.
    Ikezono Y; Koga H; Akiba J; Abe M; Yoshida T; Wada F; Nakamura T; Iwamoto H; Masuda A; Sakaue T; Yano H; Tsuruta O; Torimura T
    Mol Cancer Res; 2017 Jun; 15(6):744-752. PubMed ID: 28179411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FOXD3 is a tumor suppressor of colon cancer by inhibiting EGFR-Ras-Raf-MEK-ERK signal pathway.
    Li K; Guo Q; Yang J; Chen H; Hu K; Zhao J; Zheng S; Pang X; Zhou S; Dang Y; Li L
    Oncotarget; 2017 Jan; 8(3):5048-5056. PubMed ID: 27926503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GPNMB methylation: a new marker of potentially carcinogenic colon lesions.
    Ashktorab H; Rahi H; Nouraie M; Shokrani B; Lee E; Haydari T; Laiyemo AO; Siegel P; Brim H
    BMC Cancer; 2018 Nov; 18(1):1068. PubMed ID: 30400781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Essential Role of DCLK1 in Pathogenesis, Diagnostic Procedures and Prognostic Stratification of Colorectal Cancer.
    Gzil A; Szylberg Ł; Jaworski D; Dominiak J; Zarębska I; Grzanka D
    Anticancer Res; 2019 Jun; 39(6):2689-2697. PubMed ID: 31177103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The recently suggested intestinal cancer stem cell marker DCLK1 is an epigenetic biomarker for colorectal cancer.
    Vedeld HM; Skotheim RI; Lothe RA; Lind GE
    Epigenetics; 2014 Mar; 9(3):346-50. PubMed ID: 24384857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of let-7e gene expression attenuates oncogenic phenotype in HCT-116 colorectal cancer cells through targeting of DCLK1 regulation.
    Khodadadi Kohlan A; Saidijam M; Amini R; Samadi P; Najafi R
    Life Sci; 2019 Jul; 228():221-227. PubMed ID: 31075231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DCLK1 Expression in Colorectal Polyps Increases with the Severity of Dysplasia.
    Takiyama A; Tanaka T; Kazama S; Nagata H; Kawai K; Hata K; Otani K; Nishikawa T; Sasaki K; Kaneko M; Emoto S; Murono K; Takiyama H; Nozawa H
    In Vivo; 2018; 32(2):365-371. PubMed ID: 29475922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of circulating cancer stem cell marker, DCLK1 but not Lgr5, in chemoradiotherapy-treated colorectal cancer patients.
    Mirzaei A; Tavoosidana G; Modarressi MH; Rad AA; Fazeli MS; Shirkoohi R; Tavakoli-Yaraki M; Madjd Z
    Tumour Biol; 2015 Jun; 36(6):4801-10. PubMed ID: 25631749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.